All Teva articles – Page 2

Business

Teva buys Auspex Pharmaceuticals for $3.2bn

2015-04-01T00:00:00Z

Generics giant will add late stage Huntingdon’s drug to CNS portfolio

Business

Teva wins generic esomeprazole race

2015-02-16T00:00:00Z

US approval of heartburn drug after Ranbaxy version was withdrawn by regulators

Business

Generics giants jostle over pain drug

2014-06-04T00:00:00Z

Mylan and Actavis contest Teva’s generic celecoxib exclusivity

Business

Generics triumph in anti-inflammatory patent battle

2014-04-25T00:00:00Z

Pfizer settles deals to allow copycat celecoxib

Business

Lilly wins cancer drug patent dispute

2014-04-07T00:00:00Z

Alimta patent will last until 2022 after US court rules in Lilly’s favour

Business

Weathering the storm

2014-01-06T00:00:00Z

Pharmaceutical industry roundup 2013

Business

5000 jobs to be cut at Teva

2013-10-14T00:00:00Z

Generics giant aims to cut costs and reinvest in R&D

Business

Two way traffic for Chinese drug licensing

2013-08-21T00:00:00Z

Western companies are seeing more value in Chinese innovation

Business

Ups and downs for erectile dysfunction drugs

2013-06-27T00:00:00Z

First new drug in a decade approved in Europe as Viagra patent expires

Business

Pfizer and Takeda win $2.15bn in patent payout

2013-06-14T00:00:00Z

Teva and Sun fined for selling generics before patent expiry

Business

Bayer $145 million animal health deal

2012-09-18T00:00:00Z

Move will strengthen anti-infective portfolio and introduce reproductive hormones

Business

Generic Actos approved

2012-08-20T00:00:00Z

Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets